Brivaracetam augments short-term depression and slows vesicle recycling

Epilepsia

Volumn 56, Issue 12, 2015, Pages 1899-1909

  Yang, Xiaofeng ^a,b,c   Bognar, Joseph ^a   He, Tianyu ^a   Mohammed, Mouhari ^a   Niespodziany, Isabelle ^d   Wolff, Christian ^d   Esguerra, Manuel ^a   Rothman, Steven M ^a   Dubinsky, Janet M ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c BEIJING INSTITUTE FOR BRAIN DISORDERS   (China)

^d UCB PHARMA   (Belgium)

Author keywords

Anticonvulsants; Antiepileptic drugs; Brivaracetam; Epilepsy; Levetiracetam; Short term depression; SV2A; Synaptic vesicle recycling

Indexed keywords

BRIVARACETAM; SUCROSE; 2 PYRROLIDONE DERIVATIVE; 2-(2-OXO-4-PROPYLPYRROLIDIN-1-YL)BUTANAMIDE; ANTICONVULSIVE AGENT; ETIRACETAM; PIRACETAM;

ANIMAL MODEL; ANIMAL TISSUE; ANTICONVULSANT ACTIVITY; ANTICONVULSANT THERAPY; ARTICLE; BRAIN ELECTROPHYSIOLOGY; CONTROLLED STUDY; DRUG EFFECT; ELECTROPHYSIOLOGICAL PROCEDURES; EXCITATORY POSTSYNAPTIC POTENTIAL; FLUORESCENCE MICROSCOPY; HIPPOCAMPAL CA1 REGION; HIPPOCAMPAL SLICE; INTRINSIC ACTIVITY; MALE; MULTIPHOTON MICROSCOPY; NONHUMAN; PRIORITY JOURNAL; RAT; SHORT TERM DEPRESSION; SYNAPSE VESICLE; SYNAPTIC TRANSMISSION; SYNAPTIC VESICLE RECYCLING; ANALOGS AND DERIVATIVES; ANIMAL; DOSE RESPONSE; DRUG EFFECTS; ELECTROPHYSIOLOGY; HIPPOCAMPUS; METABOLISM; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; ANTICONVULSANTS; CA1 REGION, HIPPOCAMPAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHYSIOLOGY; HIPPOCAMPUS; MALE; MICROSCOPY, FLUORESCENCE; PIRACETAM; PYRROLIDINONES; RATS; RATS, SPRAGUE-DAWLEY; SYNAPTIC TRANSMISSION; SYNAPTIC VESICLES;

EID: 84951567516     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/epi.13223     Document Type: Article

References (42)

1. Biton V, Berkovic SF, Abou-Khalil B, et al., Brivaracetam as adjunctive treatment for uncontrolled partial epilepsy in adults: a phase III randomized, double-blind, placebo-controlled trial. Epilepsia 2014; 55: 57-66.
2. Kaminski RM, Gillard M, Klitgaard H,. Targeting SV2A for Discovery of Antiepileptic Drugs. Jasper's Basic Mechanisms of the Epilepsies [Internet]. 4th Ed. Bethesda MD: National Center for Biotechnology Information; 2012 http://www.ncbi.nlm.nih.gov/books/NBK98183/-Accessed January 15, 2015.
3. Gillard M, Fuks B, Leclercq K, et al., Binding characteristics of brivaracetam, a selective, high affinity SV2A ligand in rat, mouse and human brain: relationship to anti-convulsant properties. Eur J Pharmacol 2011; 664: 36-44.
4. Vogl C, Mochida S, Wolff C, et al., The synaptic vesicle glycoprotein 2A ligand levetiracetam inhibits presynaptic Ca2 + channels through an intracellular pathway. Mol Pharmacol 2012; 82: 199-208.
5. Niespodziany I, Andre VM, Leclere N, et al., Brivaracetam differentially affects voltage-gated sodium currents without impairing sustained repetitive firing in neurons. CNS Neurosci Ther 2015; 21: 241-251.
6. Custer KL, Austin NS, Sullivan JM, et al., Synaptic vesicle protein 2 enhances release probability at quiescent synapses. J Neurosci 2006; 26: 1303-1313.
7. Janz R, Goda Y, Geppert M, et al., SV2A and SV2B function as redundant Ca2 + regulators in neurotransmitter release. Neuron 1999; 24: 1003-1016.
8. Yao J, Nowack A, Kensel-Hammes P, et al., Cotrafficking of SV2 and synaptotagmin at the synapse. J Neurosci 2010; 30: 5569-5578.
9. Yao J, Bajjalieh SM,. Synaptic vesicle protein 2 binds adenine nucleotides. J Biol Chem 2008; 283: 20628-20634.
10. Yang XF, Rothman SM,. Levetiracetam has a time- and stimulation-dependent effect on synaptic transmission. Seizure 2009; 18: 615-619.
11. Yang XF, Weisenfeld A, Rothman SM,. Prolonged exposure to levetiracetam reveals a presynaptic effect on neurotransmission. Epilepsia 2007; 48: 1861-1869.
12. Meehan AL, Yang X, McAdams BD, et al., A new mechanism for antiepileptic drug action: vesicular entry may mediate the effects of levetiracetam. J Neurophysiol 2011; 106: 1227-1239.
13. Fioravante D, Regehr WG,. Short-term forms of presynaptic plasticity. Curr Opin Neurobiol 2011; 21: 269-274.
14. Zucker RS, Regehr WG,. Short-term synaptic plasticity. Annu Rev Physiol 2002; 64: 355-405.
15. Galarreta M, Hestrin S,. Frequency-dependent synaptic depression and the balance of excitation and inhibition in the neocortex. Nat Neurosci 1998; 1: 587-594.
16. Matagne A, Margineanu DG, Kenda B, et al., Anti-convulsive and anti-epileptic properties of brivaracetam (ucb 34714), a high-affinity ligand for the synaptic vesicle protein, SV2A. Br J Pharmacol 2008; 154: 1662-1671.
17. Madeo M, Kovacs AD, Pearce DA,. The human synaptic vesicle protein, sv2a, functions as a galactose transporter in saccharomyces cerevisiae. J Biol Chem 2014; 289: 33066-33071.
18. Shi J, Anderson D, Lynch BA, et al., Combining modelling and mutagenesis studies of synaptic vesicle protein 2A to identify a series of residues involved in racetam binding. Biochem Soc Trans 2011; 39: 1341-1347.
19. Schindelin J, Argand-Carreras I, Frise E, et al., Fiji: an open-source platform for biological-image analysis. Nat Methods 2012; 9: 676-682.
20. Thevenaz P, Ruttimann UE, Unser M,. A pyramid approach to subpixel registration based on intensity. IEEE Trans Image Process 1998; 7: 27-41.
21. Yang X, Meehan AL, Rothman SM, et al., Seletracetam enhances short term depression in vitro. Epil Res 2015; 117: 17-22.
22. Katz B, Miledi R,. The timing of calcium action during neuromuscular transmission. J Physiol 1967; 189: 535-544.
23. Wyllie DJ, Manabe T, Nicoll RA,. A rise in postsynaptic Ca2 + potentiates miniature excitatory postsynaptic currents and AMPA responses in hippocampal neurons. Neuron 1994; 12: 127-138.
24. Rosenmund C, Stevens CF,. Definition of the readily releasable pool of vesicles at hippocampal synapses. Neuron 1996; 16: 1197-1207.
25. Rizzoli SO, Betz WJ,. Synaptic vesicle pools. Nat Rev Neurosci 2005; 6: 57-69.
26. Fernandez-Alfonso T, Ryan TA,. The kinetics of synaptic vesicle pool depletion at CNS synaptic terminals. Neuron 2004; 41: 943-953.
27. Hua Y, Sinha R, Thiel CS, et al., A readily retrievable pool of synaptic vesicles. Nat Neurosci 2011; 14: 833-839.
28. Betz W, Bewick G,. Optical analysis of synaptic vesicle recycling at the frog neuromuscular junction. Science 1992; 255: 200-203.
29. Mercier J, Holden D, Deo A, et al., Brivaracetam achieves brain SV2A occupancy faster than levetiracetam. 2014 Annual Meeting file:///G:/medline/UCB%20compounds/UCB%20work/BRVfasterNLEV-UCB-2014AESAbstr.htm, Abst. 2.3332-Accessed December 14, 2014.
30. Pyle JL, Kavalali ET, Piedras-Renteria ES, et al., Rapid reuse of readily releasable pool vesicles at hippocampal synapses. Neuron 2000; 28: 221-231.
31. Virmani T, Atasoy D, Kavalali ET,. Synaptic vesicle recycling adapts to chronic changes in activity. J Neurosci 2006; 26: 2197-2206.
32. Hua Y, Woehler A, Kahms M, et al., Blocking endocytosis enhances short-term synaptic depression under conditions of normal availability of vesicles. Neuron 2013; 80: 343-349.
33. Neher E,. What is rate-limiting during sustained synaptic activity: vesicle supply or the availability of release sites. Front Synaptic Neurosci 2010; 2: 144.
34. Schivell AE, Batchelor RH, Bajjalieh SM,. Isoform-specific, calcium-regulated interaction of the synaptic vesicle proteins SV2 and synaptotagmin. J Biol Chem 1996; 271: 27770-27775.
35. Zhang N, Gordon SL, Fritsch MJ, et al., Phosphorylation of synaptic vesicle protein 2A at Thr84 by casein kinase 1 family kinases controls the specific retrieval of synaptotagmin-1. J Neurosci 2015; 35: 2492-2507.
36. Ertunc M, Sara Y, Chung C, et al., Fast synaptic vesicle reuse slows the rate of synaptic depression in the CA1 region of hippocampus. J Neurosci 2007; 27: 341-354.
37. Gitler D, Cheng Q, Greengard P, et al., Synapsin IIa controls the reserve pool of glutamatergic synaptic vesicles. J Neurosci 2008; 28: 10835-10843.
38. Skorobogatko Y, Landicho A, Chalkley RJ, et al., O-linked beta-N-acetylglucosamine (O-GlcNAc) site thr-87 regulates synapsin I localization to synapses and size of the reserve pool of synaptic vesicles. J Biol Chem 2014; 289: 3602-3612.
39. Garcia-Perez E, Mahfooz K, Covita J, et al., Levetiracetam accelerates the onset of supply rate depression in synaptic vesicle trafficking. Epilepsia 2015; 56: 535-545.
40. Molinspiration Cheminformatics 2014. molinspiration. online 2014: Available at: http://www.molinspiration.com/cgi-bin/properties. Accessed February 4, 2013.
41. Leo AJ,. Hydrophobic parameter: measurement and calculation. Methods Enzymol 1991; 202: 544-591.
42. Mutch SA, Gadd JC, Fujimoto BS, et al., Determining the number of specific proteins in cellular compartments by quantitative microscopy. Nat Protoc 2011; 6: 1953-1968.